400 related articles for article (PubMed ID: 30799537)
1. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
2. Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction.
Xiao JW; Liu ZL; Ye PC; Luo YJ; Fu ZM; Zou Q; Wei SJ
World J Gastroenterol; 2015 Sep; 21(34):9999-10007. PubMed ID: 26379405
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
[TBL] [Abstract][Full Text] [Related]
4. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
[TBL] [Abstract][Full Text] [Related]
6. A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.
Blank S; Rachakonda S; Keller G; Weichert W; Lordick F; Langer R; Springfeld C; Bruckner T; Becker K; Kumar R; Ott K
BMC Cancer; 2014 Feb; 14():58. PubMed ID: 24490800
[TBL] [Abstract][Full Text] [Related]
7. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
Sun L; Chen F; Shi W; Qi L; Zhao Z; Zhang J
Diagn Pathol; 2014 Jul; 9():125. PubMed ID: 25029906
[TBL] [Abstract][Full Text] [Related]
9. Comparison on Clinicopathological Features and Prognosis Between Esophagogastric Junctional Adenocarcinoma (Siewert II/III Types) and Distal Gastric Adenocarcinoma: Retrospective Cohort Study, a Single Institution, High Volume Experience in China.
Liu K; Zhang W; Chen X; Chen X; Yang K; Zhang B; Chen Z; Zhou Z; Hu J
Medicine (Baltimore); 2015 Aug; 94(34):e1386. PubMed ID: 26313779
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
[TBL] [Abstract][Full Text] [Related]
11. Tumor volume of resectable adenocarcinoma of the esophagogastric junction at multidetector CT: association with regional lymph node metastasis and N stage.
Li R; Chen TW; Hu J; Guo DD; Zhang XM; Deng D; Li H; Chen XL; Tang HJ
Radiology; 2013 Oct; 269(1):130-8. PubMed ID: 23657894
[TBL] [Abstract][Full Text] [Related]
12. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
Bösing NM; Heise JW; Goretzki PE; Sarbia M; Röher HD
Chirurg; 2004 Nov; 75(11):1088-97. PubMed ID: 15168031
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
[TBL] [Abstract][Full Text] [Related]
14. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer?
Gertler R; Stein HJ; Loos M; Langer R; Friess H; Feith M
Am J Surg Pathol; 2011 Oct; 35(10):1512-22. PubMed ID: 21934477
[TBL] [Abstract][Full Text] [Related]
15. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.
Hasegawa S; Yoshikawa T; Cho H; Tsuburaya A; Kobayashi O
World J Surg; 2009 Jan; 33(1):95-103. PubMed ID: 18958523
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.
Reim D; Gertler R; Novotny A; Becker K; zum Büschenfelde CM; Ebert M; Dobritz M; Langer R; Hoefler H; Friess H; Schumacher C
Ann Surg Oncol; 2012 Jul; 19(7):2108-18. PubMed ID: 22130620
[TBL] [Abstract][Full Text] [Related]
19. Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction.
Reynolds JV; Ravi N; Muldoon C; Larkin JO; Rowley S; O'Byrne K; Hollywood D; O'Toole D
World J Surg; 2010 Dec; 34(12):2821-9. PubMed ID: 20827475
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.
von Rahden BH; Stein HJ; Feith M; Becker K; Siewert JR
J Clin Oncol; 2005 Feb; 23(4):874-9. PubMed ID: 15681533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
